Novocure's lung cancer therapy succeeds in late-stage trial-March 2024-www.financetom.com

Novocure's lung cancer therapy succeeds in late-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novocure's lung cancer therapy succeeds in late-stage trial

Mar 27, 2024 5:40 AM

March 27 (Reuters) - Novocure ( NVCR ) said on Wednesday

that its cancer therapy met the main goal of a late-stage trial

testing it as a treatment for a type of lung cancer.

Previous page： Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing Next page： Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing

Dec 16, 2024

04:02 AM EST, 12/16/2024 (MT Newswires) -- Suma Krishnan, 10% Owner, Director, President, Research & Development, on December 13, 2024, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,240,023. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,153,144 shares of the company, with 1,475,882 shares held directly and 1,677,262 controlled indirectly....

Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing

Dec 16, 2024

04:00 AM EST, 12/16/2024 (MT Newswires) -- Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on December 13, 2024, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,240,023. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,153,144 shares of the company, with 1,537,262 shares held directly and 1,615,882...

Globalstar Insider Sold Shares Worth $7,752,850, According to a Recent SEC Filing

Dec 16, 2024

03:59 AM EST, 12/16/2024 (MT Newswires) -- Timothy Evan Taylor, Director, Vice President, Finance & Operations, on December 11, 2024, sold 3,500,000 shares in Globalstar ( GSAT ) for $7,752,850. Following the Form 4 filing with the SEC, Taylor has control over a total of 9,837,893 shares of the company, with 3,454,244 shares held directly and 6,383,649 controlled indirectly. SEC...

Akoustis Technologies Files for Chapter 11 Bankruptcy

Dec 16, 2024

03:56 AM EST, 12/16/2024 (MT Newswires) -- Akoustis Technologies ( AKTS ) said Monday it filed for a Chapter 11 relief in a bankruptcy court for the District of Delaware. The move follows a recent court ruling ordering the company to pay $59 million in damages and fees in a patent dispute with Qorvo ( QRVO ) , the company...